These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 1125653)
1. Cutaneous Manifestations of Chronic Kidney Disease, Dialysis and Post-Renal Transplant: A Review. Goel V; Sil A; Das A Indian J Dermatol; 2021; 66(1):3-11. PubMed ID: 33911288 [TBL] [Abstract][Full Text] [Related]
2. Clinicoepidemiological study of skin manifestations in patients of chronic renal failure on hemodialysis. Deshmukh SP; Sharma YK; Dash K; Chaudhari NC; Deo KS Indian Dermatol Online J; 2013 Jan; 4(1):18-21. PubMed ID: 23439945 [TBL] [Abstract][Full Text] [Related]
3. A prospective study of cutaneous abnormalities in patients with chronic kidney disease. Thomas EA; Pawar B; Thomas A Indian J Nephrol; 2012 Mar; 22(2):116-20. PubMed ID: 22787313 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. Bertagna XY; Stone WJ; Nicholson WE; Mount CD; Orth DN J Clin Invest; 1981 Jan; 67(1):124-33. PubMed ID: 6256410 [TBL] [Abstract][Full Text] [Related]
7. [Recent data on the group of melanotropic and lipotropic pituitary hormones (MSH-LPH) and on the brain morphinomimetic peptides (endorphins)]. Bertagna X; Girard F Ann Endocrinol (Paris); 1978; 39(3):201-13. PubMed ID: 214012 [TBL] [Abstract][Full Text] [Related]
8. Hormones and skin pigmentation in the mammal. Thody AJ; Smith AG Int J Dermatol; 1977 Oct; 16(8):657-64. PubMed ID: 199552 [No Abstract] [Full Text] [Related]
9. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure. Smith AG; Shuster S; Comaish JS; Plummer NA; Thody AJ; Alvarez-Ude F; Kerr DN Br Med J; 1975 Mar; 1(5959):658-9. PubMed ID: 1125653 [TBL] [Abstract][Full Text] [Related]
11. Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone. Smith AG; Shuster S; Thody AJ; Alvarez-Ude F; Kerr DN Br Med J; 1976 Apr; 1(6014):874-6. PubMed ID: 769907 [TBL] [Abstract][Full Text] [Related]
12. Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH. Bertagna X; Donnadieu M; Idatte JM; Girard F J Clin Endocrinol Metab; 1977 Dec; 45(6):1179-86. PubMed ID: 201658 [TBL] [Abstract][Full Text] [Related]
13. Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure. Smith AG; Shuster S; Bomford A; Williams R J Invest Dermatol; 1978 Jun; 70(6):326-7. PubMed ID: 649979 [TBL] [Abstract][Full Text] [Related]
14. Measurement of immunoreactive alpha-melanocyte-stimulating hormone in the blood of rainbow trout kept under various conditions. Bowley TJ; Rance TA; Baker BI J Endocrinol; 1983 May; 97(2):267-75. PubMed ID: 6854194 [TBL] [Abstract][Full Text] [Related]